Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-11-04
2000-01-04
Owens, Amelia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514460, 549292, A61K 31335, C07D31500
Patent
active
RE0364819
ABSTRACT:
Novel 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors are useful as antihypercholesterolemic agents and are represented by the following general structural formulae (I) and (II): ##STR1##
REFERENCES:
patent: 4231938 (1980-11-01), Monaghan et al.
patent: 4294846 (1981-10-01), Albers-Schonberg et al.
patent: 4351844 (1982-09-01), Patchett et al.
patent: 4361515 (1982-11-01), Terahara et al.
patent: 4376863 (1983-03-01), Lam
patent: 4444784 (1984-04-01), Hoffman et al.
patent: 4448979 (1984-05-01), Terahara et al.
patent: 4450171 (1984-05-01), Hoffman et al.
patent: 4517373 (1985-05-01), Terahara et al.
patent: 4537859 (1985-08-01), Terahara et al.
patent: 4661483 (1987-04-01), Hoffman et al.
patent: 4668699 (1987-05-01), Hoffman et al.
patent: 4766145 (1988-08-01), Lee et al.
patent: 4795811 (1989-01-01), Graham et al.
patent: 4831165 (1989-05-01), Schuda et al.
patent: 4841074 (1989-06-01), Lee et al.
patent: 4847306 (1989-07-01), Lee et al.
patent: 4855456 (1989-08-01), Lee et al.
patent: 4857546 (1989-08-01), Duggan et al.
patent: 4857547 (1989-08-01), Hoffman et al.
patent: 4876364 (1989-10-01), Schuda et al.
patent: 4894465 (1990-01-01), Lee et al.
patent: 4894466 (1990-01-01), Lee et al.
patent: 4916162 (1990-04-01), Hoffman et al.
patent: 4937263 (1990-06-01), Hoffman et al.
patent: 4946864 (1990-08-01), Prugh et al.
patent: 4997755 (1991-03-01), Williamson et al.
G. E. Stokker et al., "3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Inhibitors. 1. Structural Modification of 5-Substituted 3,5, Dihydroxypentanoic Acids and Their Lactone Derivatives", J. Med. Chem., 28, pp. 347-358 (1985).
R. A. Heller et al., "3-Hydroxy-3-methylglutaryl Coenzyme A Reductase from Rat Liver", J. Biol. Chem., 251, pp. 3815-3822 (1976).
D. A. Kleinsek et al., "Purification of 3-hydroxy-3-methylglutaryl-coenzyme A reducatase from rat liver", Proc. Nat'l Acad. Sci. USA, 74, pp. 1431-1435 (1977).
S. Shefer et al., "HMG CoA reductase of intestinal mucosa and liver of the rat", J. Lipid Res., 13, pp. 402-412 (1972).
Sugiyama et al., Chemical Abstracts, 111, Abstract No. 120925n, pp. 366-367 (1989).
A. F. Rosenthal et al., "Compounds Related to a-Glycerophosphoric Acid, Phosphorylcholine and Phosphorylethanolamine", J. Amer. Chem. Soc., 80, pp. 5240-5241 (1959).
A. G. Olsson et al., "Synvinolin In Hypercholesterolaemia", The Lancet, pp. 390-391 Aug. 16, 1986.
P. Weisweiler et al., "Colestipol Plus Fenofibrate Versus Synvinolin In Familial Hypercholesterolaemia", The Lancet, pp. 1212-1213, Nov. 22, 1986.
A. F. Stalenhoef et al., "Effect of Synvinolin, a New Cholesterol Synthesis Inhibitor, in Familial Hypercholesterolemia", Arteriosclerosis, vol. 6, No. 5, Sep./Oct. 1986.
M.J.T.M. Mol et al., "Effects of Synvinolin (MK-733) On Plasma Lipids In Familial Hypercholesterolaemia", The Lancet, pp. 936-939, Oct. 25, 1986.
S. M. Grundy et al., "Effects of Mevinolin on Plasma Lipoprotein (LP) Metabolism in Moderate Hypercholesterolemia", ABSTRACTS Circulation, vol. 70, Supp. II, p. 268, No. 1072 (1984).
D. W. Bilheimer et al., "Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes", Proc. Natl. Acad. Sci. USA, vol. 80, pp. 4124-4128 (Jul. 1983).
D. W. Bilheimer et al., "Mevinolin Stimulates Receptor-Mediated Clearance of LDL in Familial Hypercholesterolemia (FH) Heterozygotes", Clin. Res. 31, No. 2, p. 544A (1983).
J. A. Tobert et al., Cholesterol-lowering effect of Mevinolin, an Inhibitor of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase, in Healthy Volunteers, J. Clin. Invest. (USA), 69(4), PP. 913-919 (Apr. 1982).
J. A. Tobert et al., "Rapid and Substantial Lowering of Human Serum Cholesterol by Mevinolin (MK-803), An Inhibitor of Hydroxymethylglutaryl-Coenzyme A Reductase", Atherosclerosis, 41, pp. 61-65 (1982).
Halczenko Wasyl
Hartman George D.
Hensens Otto D.
Houck David R.
Inamine Edward S.
Merck & Co. , Inc.
Owens Amelia
Quagliato Carol S.
Winokur Melvin
LandOfFree
HMG-CoA reductase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with HMG-CoA reductase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HMG-CoA reductase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1062504